MYCN and cancer: Detailed immunoblot analyses revealed that compounds 11a and 11b decreased the expression of endogenousGLI1 protein and its target genes associated with tumor progressionand proliferation, such as Cyclin D1, N-Myc, and Bcl-2, in A549 andDU-145 cancer cells.